Radiotherapy Patient Education With Virtual Reality
RADIOACTIVE - Radiotherapy Patient Education With Virtual Reality
University of Miami
150 participants
Dec 4, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this research study is to investigate the impact of virtual reality experiences on individuals undergoing radiotherapy, aiming to assess whether this immersive technology can reduce anxiety and enhance patient overall treatment satisfaction. By comparing different virtual reality techniques and a standard informational video, the study seeks to identify optimal strategies for leveraging virtual reality to improve the patient experience during radiotherapy.
Eligibility
Inclusion Criteria4
- Histologically proven cancer
- ≥18 years of age
- Able to speak and read English and/or Spanish
- Receiving radiotherapy at the University of Miami
Exclusion Criteria8
- Prior radiation therapy
- Pregnant or nursing women
- Men or women of childbearing potential who are unwilling to employ adequate contraception
- Patients unable to consent or are prisoners
- Participants with impaired decision-making capacity
- Any serious illness or medical condition that would compromise patient safety during virtual reality as judged by the treating physician
- Unwilling or unable to watch virtual reality video
- Unwilling to fill out survey forms
Interventions
A 30-minute informational video. The two dimensional (2D) video provides information about the radiotherapy process. Participants will receive this one-time intervention in-person, prior to treatment.
A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a first-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.
A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a third-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06506435